ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,807 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselFoRx Therapeutics AG
FoRx Therapeutics AG Logo
Verified· 4 sources

FoRx Therapeutics AG

Summary

About the company

The core activity of FoRx Therapeutics AG is the development of active ingredients for cancer treatment, in particular the development of first-in-class compounds for the treatment of cancer, with a focus on inhibiting targets involved in the repair of collapsed DNA replication forks.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Development of cancer drugs
Preclinical and clinical development of precise therapeutics for therapy-resistant cancers, focusing on DNA replication stress and DNA damage response pathways.
PARG inhibitor FORX-428
Lead program for a potent and selective PARG inhibitor in Phase 1 clinical development for the treatment of therapy-resistant cancers.
Research on DNA replication stress
Research into the biological role of DNA replication stress and the targeted modulation of DNA repair pathways in cancer cells.
Pipeline development of additional drug programs
Development of additional programs in lead optimization and lead identification, including FORX-002 and FORX-003 for DNA damage response and replication stress.
Investor Relations
Investor information, company overview, financing and development updates, and contacts for institutional, corporate and strategic investors.
Reviews

Aggregated rating

Aggregated rating
4
of 5

Aggregated from 4 reviews across all connected sources

Sources
GGoogle44
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

December 18, 2025Media
FoRx Therapeutics raises $50 million to advance clinical trials
startupticker.ch

Knowledge

No knowledge articles yet

Once FoRx Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

FoRx Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank FoRx Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of FoRx Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Lichtstrasse 35
4056 Basel
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-336.934.781
Founded
2024 · 2 years
Last commercial register change
March 31, 2026
Employees
21 to 50

Similar companies

SA
SpiroChem AG
Basel
SA
Scailyte AG
Basel
ST
Synendos Therapeutics AG
Basel
TT
TargImmune Therapeutics AG
Basel